Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

8.18
Delayed Data
As of Feb 12
 +0.21 / +2.63%
Today’s Change
7.76
Today|||52-Week Range
22.66
-33.98%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close7.97
Today’s open8.28
Day’s range7.87 - 8.43
Volume187,801
Average volume (3 months)145,425
Market cap$240.2M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-120.60%
Earnings growth (this year)+31.87%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.18

Competitors

 Today’s
change
Today’s
% change
VTLVital Therapies Inc+0.40+5.34%
OREXOrexigen Therapeutic...-0.01-0.61%
LBIOLion Biotechnologies...+0.36+7.81%
ZGNXZogenix Inc+0.27+2.84%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateFebruary 15, 2016
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$0.00
Annual profit (last year)-$57.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers